Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Durvalumab with carboplatin/paclitaxel and bevacizumab followed by durvalumab and bevacizumab with or without olaparib maintenance in newly diagnosed non-BRCA-mutated advanced ovarian cancer.

Annals of oncology : official journal of the European Society for Medical Oncology·2025
Same author

Overall survival in patients with endometrial cancer treated with dostarlimab plus carboplatin-paclitaxel in the randomized ENGOT-EN6/GOG-3031/RUBY trial.

Annals of oncology : official journal of the European Society for Medical Oncology·2024
Same author

Inclusion, diversity, equity, and access (IDEA) in gynecologic cancer clinical trials: A joint statement from GOG foundation and Society of Gynecologic Oncology (SGO).

Gynecologic oncology·2023
Same author

Rosette-induced separation of T cells by acoustophoresis.

Biomicrofluidics·2022
Same author

Pilot study of women's perspectives when abnormal uterine bleeding occurs during perimenopause.

Climacteric : the journal of the International Menopause Society·2022
Same author

A phase II trial of bevacizumab and rucaparib in recurrent carcinoma of the cervix or endometrium.

Gynecologic oncology·2022
Same journal

The Brief Case: Wound infection following a penetrating and cutting instrument injury: a case report.

Journal of clinical microbiology·2026
Same journal

Ebola laboratory preparedness at frontline hospitals: can we or can't we?

Journal of clinical microbiology·2026
Same journal

Reporting macrolide-resistant <i>Mycoplasma pneumoniae</i>: a diagnostic obligation?

Journal of clinical microbiology·2026
Same journal

Diagnostic value of HHV-6A/B genotyping in immunocompromised adults.

Journal of clinical microbiology·2026
Same journal

Multicenter performance evaluation of the Simplexa <i>C. auris</i> Direct assay for the detection of <i>Candida auris</i> colonization in bilateral axilla/groin swabs.

Journal of clinical microbiology·2026
Same journal

Comparison of blood culture contamination rates with standard practice versus two blood diversion devices at a single institution.

Journal of clinical microbiology·2026
See all related articles

Related Experiment Video

Updated: Jul 4, 2026

Using a Pan-Viral Microarray Assay (Virochip) to Screen Clinical Samples for Viral Pathogens
13:45

Using a Pan-Viral Microarray Assay (Virochip) to Screen Clinical Samples for Viral Pathogens

Published on: April 27, 2011

Evaluation of linear array human papillomavirus genotyping using automatic optical imaging software.

J Jeronimo1, N Wentzensen, R Long

  • 1PATH, 1455 NW Leary Way, Seattle, WA 98107, USA. jjeronimo@path.org

Journal of Clinical Microbiology
|June 14, 2008
PubMed
Summary
This summary is machine-generated.

Automated software for reading human papillomavirus (HPV) genotyping tests shows high accuracy compared to visual inspection. This technology could improve the evaluation of complex HPV infections, especially in cases of multiple concurrent infections.

More Related Videos

ampliPHOX Colorimetric Detection on a DNA Microarray for Influenza
09:32

ampliPHOX Colorimetric Detection on a DNA Microarray for Influenza

Published on: June 9, 2011

Use of Interferon-&gamma; Enzyme-linked Immunospot Assay to Characterize Novel T-cell Epitopes of Human Papillomavirus
13:41

Use of Interferon-γ Enzyme-linked Immunospot Assay to Characterize Novel T-cell Epitopes of Human Papillomavirus

Published on: March 8, 2012

Related Experiment Videos

Last Updated: Jul 4, 2026

Using a Pan-Viral Microarray Assay (Virochip) to Screen Clinical Samples for Viral Pathogens
13:45

Using a Pan-Viral Microarray Assay (Virochip) to Screen Clinical Samples for Viral Pathogens

Published on: April 27, 2011

ampliPHOX Colorimetric Detection on a DNA Microarray for Influenza
09:32

ampliPHOX Colorimetric Detection on a DNA Microarray for Influenza

Published on: June 9, 2011

Use of Interferon-&gamma; Enzyme-linked Immunospot Assay to Characterize Novel T-cell Epitopes of Human Papillomavirus
13:41

Use of Interferon-γ Enzyme-linked Immunospot Assay to Characterize Novel T-cell Epitopes of Human Papillomavirus

Published on: March 8, 2012

Area of Science:

  • Virology
  • Medical Diagnostics
  • Biotechnology

Background:

  • Carcinogenic human papillomavirus (HPV) types necessitate individual consideration in research.
  • HPV genotyping assays hold potential clinical value pending FDA approval.
  • The Roche Linear Array (LA) HPV genotyping test is widely utilized.

Purpose of the Study:

  • To evaluate the feasibility and value of automated reading for LA HPV genotyping results.
  • To compare automated optical density measurements with unmagnified visual examination.
  • To assess the impact of automated reading on interpreting equivocal results, particularly in cases of multiple infections.

Main Methods:

  • Custom optical imaging software was developed to measure LA band optical densities.
  • Visual examination of LA results was compared against automated measurements.
  • Statistical analysis was performed to correlate visual and automated assessments.

Main Results:

  • Visual and automated measurements demonstrated a high degree of association.
  • Automated measurements significantly correlated with visual strength categories (P < 0.001).
  • Automated reading effectively distinguished negative and positive results and showed potential for improving equivocal result interpretation, especially with multiple HPV infections.

Conclusions:

  • Automated reading of HPV genotyping tests is a promising development.
  • The technology may enhance the accuracy and objectivity of HPV test interpretation.
  • Further optimization of hardware and software is recommended for clinical application.